RA
BFRI icon

Rosalind Advisors’s Biofrontera BFRI Stock Holding History

Rosalind Advisors’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
1,275,609
+111,647
+10% +$110K 0.45% 25
2026
Q1 		$942K Buy
1,163,962
+23,198
+2% +$20K 0.38% 33
2025
Q4 		$650K Hold
1,140,764
– – 0.23% 34
2025
Q3 		$1.12M Buy
1,140,764
+164,316
+17% +$149K 0.38% 28
2025
Q2 		$695K Buy
976,448
+332,055
+52% +$232K 0.33% 28
2025
Q1 		$516K Sell
644,393
-167,525
-21% -$172K 0.25% 31
2024
Q4 		$885K Buy
811,918
+316,428
+64% +$299K 0.45% 27
2024
Q3 		$659K Sell
495,490
-8,771
-2% -$10K 0.42% 26
2024
Q2 		$453K Hold
504,261
– – 0.35% 34
2024
Q1 		$777K Buy
+504,261
New +$699K 0.73% 28

Other funds holding BFRI

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Rosalind Advisors's BFRI Position: Q2 2026 in Review

Rosalind Advisors increased its Biofrontera (BFRI) stake by 9.6% in Q2 2026, buying an estimated $110K and bringing the position to 1,275,609 shares worth $1.21M. The position accounts for 0.45% of the portfolio, ranked #25.

Rosalind Advisors first reported a position in BFRI in Q1 2024 and has held it in 10 quarters since. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • Rosalind Advisors held 1,275,609 shares of Biofrontera worth $1.21M as of Q2 2026.
  • Rosalind Advisors bought 111,647 Biofrontera shares in Q2 2026, an estimated $110K.
  • Biofrontera made up 0.45% of Rosalind Advisors's portfolio in Q2 2026, its #25 holding.
  • Rosalind Advisors first reported a position in Biofrontera in Q1 2024 and has held it in 10 quarters since.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.